We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

1 hedge funds and large institutions have $11 invested in CERo Therapeutics Warrants in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

2.72% less ownership

Funds ownership: 2.72% → 0% (-2.7%)

50% less capital invested

Capital invested by funds: $22 → $11 (-$11)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CEROW Hedge Fund Activity: Q1 2026 in Review

1 of the 8,205 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q1 2026, worth a combined $11 — down 50% from $22 a quarter earlier.

Fund positioning in CEROW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held CERo Therapeutics Warrants (CEROW) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $11 of CERo Therapeutics Warrants stock for Q1 2026, down 50% quarter-over-quarter.
  • 0 funds opened new CERo Therapeutics Warrants positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.